StonvexLoading…
StonvexStonvexStonvexCore line items from EIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.10B | $19.32B | $14.10B | $8.35B |
Operating Income | $1.07B | $7.09B | $4.34B | $2.91B |
Net Income | $531.00M | $4.46B | $2.61B | $1.78B |
EPS (Diluted) | $1.37 | $11.55 | $6.76 | $4.61 |
Total Assets | $94.47B | $94.03B | $90.49B | $88.81B |
Total Liabilities | $75.59B | $74.77B | $71.16B | $69.95B |
Cash & Equivalents | $168.00M | $158.00M | $364.00M | $140.00M |
Free Cash Flow OCF − CapEx | $-112.00M | $-715.00M | $-396.00M | $-1.01B |
Shares Outstanding | 384.79M | 384.79M | 384.79M | 384.79M |